920 related articles for article (PubMed ID: 22571976)
1. Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.
Moldzio R; Pacher T; Krewenka C; Kranner B; Novak J; Duvigneau JC; Rausch WD
Phytomedicine; 2012 Jun; 19(8-9):819-24. PubMed ID: 22571976
[TBL] [Abstract][Full Text] [Related]
2. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF.
Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J
Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005
[TBL] [Abstract][Full Text] [Related]
3. Secalonic acid A protects dopaminergic neurons from 1-methyl-4-phenylpyridinium (MPP⁺)-induced cell death via the mitochondrial apoptotic pathway.
Zhai A; Zhu X; Wang X; Chen R; Wang H
Eur J Pharmacol; 2013 Aug; 713(1-3):58-67. PubMed ID: 23665112
[TBL] [Abstract][Full Text] [Related]
4. Relationship between NMDA receptor expression and MPP+ toxicity in cultured dopaminergic cells.
Church WH; Hewett SJ
J Neurosci Res; 2003 Sep; 73(6):811-7. PubMed ID: 12949907
[TBL] [Abstract][Full Text] [Related]
5. The effect of glia-conditioned medium on dopamine neurons in culture. Modulation of apoptosis, tyrosine hydroxylase expression and 1-methyl-4-phenylpyridinium toxicity.
Mena MA; Casarejos MJ; García de Yébenes J
J Neural Transm (Vienna); 1999; 106(11-12):1105-23. PubMed ID: 10651107
[TBL] [Abstract][Full Text] [Related]
6. Human dental pulp stem cells protect mouse dopaminergic neurons against MPP+ or rotenone.
Nesti C; Pardini C; Barachini S; D'Alessandro D; Siciliano G; Murri L; Petrini M; Vaglini F
Brain Res; 2011 Jan; 1367():94-102. PubMed ID: 20854799
[TBL] [Abstract][Full Text] [Related]
7. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease.
Lastres-Becker I; Molina-Holgado F; Ramos JA; Mechoulam R; Fernández-Ruiz J
Neurobiol Dis; 2005; 19(1-2):96-107. PubMed ID: 15837565
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective antioxidants from marijuana.
Hampson AJ; Grimaldi M; Lolic M; Wink D; Rosenthal R; Axelrod J
Ann N Y Acad Sci; 2000; 899():274-82. PubMed ID: 10863546
[TBL] [Abstract][Full Text] [Related]
9. CDP-choline reduces dopaminergic cell loss induced by MPP(+) and glutamate in primary mesencephalic cell culture.
Radad K; Gille G; Xiaojing J; Durany N; Rausch WD
Int J Neurosci; 2007 Jul; 117(7):985-98. PubMed ID: 17613109
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological interaction of the effects of delta 9-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in rats.
Zuardi AW; Teixeira NA; Karniol IC
Arch Int Pharmacodyn Ther; 1984 May; 269(1):12-9. PubMed ID: 6087750
[TBL] [Abstract][Full Text] [Related]
11. Effects of the cannabinoids on physical properties of brain membranes and phospholipid vesicles: fluorescence studies.
Hillard CJ; Harris RA; Bloom AS
J Pharmacol Exp Ther; 1985 Mar; 232(3):579-88. PubMed ID: 2983062
[TBL] [Abstract][Full Text] [Related]
12. Magnesium exerts both preventive and ameliorating effects in an in vitro rat Parkinson disease model involving 1-methyl-4-phenylpyridinium (MPP+) toxicity in dopaminergic neurons.
Hashimoto T; Nishi K; Nagasao J; Tsuji S; Oyanagi K
Brain Res; 2008 Mar; 1197():143-51. PubMed ID: 18242592
[TBL] [Abstract][Full Text] [Related]
13. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
Otto D; Unsicker K
J Neurosci Res; 1993 Mar; 34(4):382-93. PubMed ID: 8097265
[TBL] [Abstract][Full Text] [Related]
14. A morphometric analysis of bipolar and multipolar TH-IR neurons treated with the neurotoxin MPP+ in co-cultures from mesencephalon and striatum of embryonic C57BL/6 mice.
Koutsilieri E; Chen TS; Kruzik P; Rausch WD
J Neurosci Res; 1995 Jun; 41(2):197-205. PubMed ID: 7650755
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia.
Ryan D; Drysdale AJ; Pertwee RG; Platt B
Neurosci Lett; 2006 Nov; 408(3):236-41. PubMed ID: 16997463
[TBL] [Abstract][Full Text] [Related]
16. Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons.
Bilsland J; Roy S; Xanthoudakis S; Nicholson DW; Han Y; Grimm E; Hefti F; Harper SJ
J Neurosci; 2002 Apr; 22(7):2637-49. PubMed ID: 11923429
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling of ATP-depletion and cell death in human dopaminergic neurons.
Pöltl D; Schildknecht S; Karreman C; Leist M
Neurotoxicology; 2012 Aug; 33(4):769-79. PubMed ID: 22206971
[TBL] [Abstract][Full Text] [Related]
18. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum.
Xu G; Xiong Z; Yong Y; Wang Z; Ke Z; Xia Z; Hu Y
Neuroscience; 2010 Apr; 167(1):174-84. PubMed ID: 20123001
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of the stimulus produced by the mixture of cannabidiol with delta 9-tetrahydrocannabinol.
Zuardi AW; Finkelfarb E; Bueno OF; Musty RE; Karniol IG
Arch Int Pharmacodyn Ther; 1981 Jan; 249(1):137-46. PubMed ID: 6261703
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease.
Zhang D; Anantharam V; Kanthasamy A; Kanthasamy AG
J Pharmacol Exp Ther; 2007 Sep; 322(3):913-22. PubMed ID: 17565007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
